1. Home
  2. TUSK vs NKTX Comparison

TUSK vs NKTX Comparison

Compare TUSK & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TUSK
  • NKTX
  • Stock Information
  • Founded
  • TUSK 2014
  • NKTX 2015
  • Country
  • TUSK United States
  • NKTX United States
  • Employees
  • TUSK N/A
  • NKTX N/A
  • Industry
  • TUSK Oilfield Services/Equipment
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TUSK Energy
  • NKTX Health Care
  • Exchange
  • TUSK Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • TUSK 128.0M
  • NKTX 131.3M
  • IPO Year
  • TUSK 2016
  • NKTX 2020
  • Fundamental
  • Price
  • TUSK $2.49
  • NKTX $1.93
  • Analyst Decision
  • TUSK
  • NKTX Strong Buy
  • Analyst Count
  • TUSK 0
  • NKTX 6
  • Target Price
  • TUSK N/A
  • NKTX $15.00
  • AVG Volume (30 Days)
  • TUSK 255.4K
  • NKTX 668.9K
  • Earning Date
  • TUSK 05-07-2025
  • NKTX 05-20-2025
  • Dividend Yield
  • TUSK N/A
  • NKTX N/A
  • EPS Growth
  • TUSK N/A
  • NKTX N/A
  • EPS
  • TUSK N/A
  • NKTX N/A
  • Revenue
  • TUSK $207,208,000.00
  • NKTX N/A
  • Revenue This Year
  • TUSK N/A
  • NKTX N/A
  • Revenue Next Year
  • TUSK $28.22
  • NKTX N/A
  • P/E Ratio
  • TUSK N/A
  • NKTX N/A
  • Revenue Growth
  • TUSK N/A
  • NKTX N/A
  • 52 Week Low
  • TUSK $1.68
  • NKTX $1.31
  • 52 Week High
  • TUSK $4.94
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • TUSK 50.94
  • NKTX 51.05
  • Support Level
  • TUSK $2.36
  • NKTX $1.81
  • Resistance Level
  • TUSK $2.81
  • NKTX $2.16
  • Average True Range (ATR)
  • TUSK 0.22
  • NKTX 0.16
  • MACD
  • TUSK -0.02
  • NKTX -0.02
  • Stochastic Oscillator
  • TUSK 28.89
  • NKTX 25.53

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: